Helicobacter pylori is a spiral-shaped, gram-negative bacterium that lives in the stomach lining — one of the only organisms capable of surviving in the extreme acid environment of the gastric mucosa. It achieves this by producing urease, an enzyme that converts urea (abundant in the stomach) into ammonia, locally neutralizing acid around the bacteria. H. pylori burrows into the mucus layer coating the stomach, causing inflammation, damaging the mucosal protective barrier, and in many cases persisting for the lifetime of the host if untreated.
It is transmitted via the fecal-oral and oral-oral routes — contaminated water, unwashed food, and close contact with infected individuals (sharing utensils, saliva exposure). Infection typically occurs in childhood, especially in settings with poor sanitation, and may persist for 30–50 years with no symptoms. The discovery that H. pylori — not stress or diet alone — was the primary cause of peptic ulcers fundamentally changed gastroenterology and earned Barry Marshall and Robin Warren the Nobel Prize in Physiology or Medicine in 2005.
The majority of infected individuals are asymptomatic for their entire lives. When symptoms do occur, they typically reflect either H. pylori–induced gastritis (inflammation of the stomach lining) or a developed peptic ulcer (erosion through the mucosal barrier into the stomach or duodenal wall).
Burning or gnawing upper abdominal pain — classically centered in the epigastrium (center of the upper abdomen, between the navel and breastbone). The pain is typically dull-to-burning rather than sharp, and may be worse when the stomach is empty (2–3 hours after a meal or at night) because the inflamed mucosa is exposed to acid without food buffering.
Nausea — often present in the morning before eating; tends to improve after eating (unlike the nausea of gastroparesis, which worsens after eating)
Bloating and early satiety — feeling full very quickly during a meal; a common but non-specific symptom
Burping / belching — the urease enzyme produces ammonia and CO2 as byproducts; excess gas production is common
Loss of appetite — particularly in active gastritis; food may aggravate discomfort
Important non-symptom: H. pylori gastritis does NOT reliably produce heartburn or acid reflux (those symptoms are more typical of GERD). Some H. pylori patients have reduced acid production (atrophic gastritis) rather than excess acid.
These symptoms indicate significant mucosal damage and possible ulcer complications:
| Test | How It Works | Accuracy | When to Use |
|---|---|---|---|
| Urea Breath Test (UBT) | Patient swallows labeled urea; if H. pylori is present, urease converts it to labeled CO2 measured in breath within 20–30 min | Sensitivity 95%, Specificity 96% — the gold standard non-invasive test | Initial diagnosis; confirming eradication 4+ weeks post-treatment. Must stop PPIs 2 weeks before and antibiotics 4 weeks before |
| Stool Antigen Test (HpSA) | Monoclonal antibody test detects H. pylori proteins in stool sample | Sensitivity 94%, Specificity 97% — comparable to UBT for both diagnosis and cure confirmation | Initial testing and post-eradication testing; convenient at-home collection possible |
| Blood Serology (IgG antibodies) | Measures antibodies to H. pylori; stays positive after successful eradication for 6–12 months | Sensitivity 85%, Specificity 79% — lowest accuracy; cannot confirm eradication | Epidemiological surveys only; NOT recommended for clinical diagnosis or post-treatment testing because it cannot distinguish active from past infection |
| Endoscopy + Biopsy (CLO test / histology / culture) | Upper endoscopy takes biopsies from antrum and body; rapid urease test (CLO), microscopy, or culture performed on tissue | Highest accuracy; culture provides antibiotic susceptibility data | When endoscopy is indicated for other reasons (alarm symptoms, age >45 new dyspepsia); allows biopsies to test for gastric cancer/atrophy simultaneously |
H. pylori eradication requires a multi-drug regimen because antibiotic resistance — particularly to clarithromycin (the backbone of traditional triple therapy) — has risen significantly. US clarithromycin resistance rates now approach 30–40% in some regions, which is why many guidelines have moved away from classic triple therapy toward more effective quadruple or sequential regimens.
Bismuth Quadruple Therapy (preferred where clarithromycin resistance is high):
Concomitant Quadruple Therapy (alternative first-line):
Vonoprazan-based therapy (newer, FDA-approved 2022):
Always confirm eradication: Test with UBT or stool antigen at least 4 weeks after completing therapy and at least 2 weeks off PPIs. H. pylori is not "cured" until a negative post-treatment test is confirmed.
Successful H. pylori eradication is not the end of the story. The heavy antibiotic courses used in eradication regimens significantly disrupt the gut microbiome — particularly reducing Lactobacillus and Bifidobacterium populations while temporarily enriching opportunistic organisms. Restoration of gut health after eradication should be an active process.
Probiotics during and after eradication: Multiple meta-analyses (including a Cochrane-level 2022 analysis of 44 RCTs) confirm that taking a multi-strain probiotic concurrently with H. pylori eradication therapy reduces GI side effects (diarrhea, nausea) by 35–50% and modestly improves eradication rates (+5–8%). Take the probiotic at least 2 hours away from antibiotic doses to avoid killing the probiotic bacteria. Continue for 4–8 weeks post-treatment.
Mastic gum (Pistacia lentiscus resin): Historically used for GI complaints, mastic gum has demonstrated bacteriostatic activity against H. pylori in vitro and in small RCTs as an adjunct. It does not replace antibiotic eradication therapy but may have a role in supporting mucosal healing post-treatment. 350mg three times daily with meals is the common studied dose.
Mucosal healing: H. pylori–induced gastritis typically resolves within 2–8 weeks after successful eradication. Continuing PPI therapy for 4–8 weeks post-eradication (in patients with documented ulcers) allows complete mucosal healing and reduces ulcer recurrence risk.
Multi-Strain Probiotic → Mastic Gum →As an Amazon Associate, GutCode earns from qualifying purchases made through links on this page. This does not affect the price you pay.